Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00477555
Status:
COMPLETED
Last Update Posted:
2015-10-29
First Post:
2007-05-21
Brief Title:
Hemodynamic Assessment of Mosaic Ultra Stented Heart Valve in the Aortic Position
Sponsor:
Medtronic Bakken Research Center
Organization:
Medtronic Cardiovascular
Study Overview
Official Title:
Mosaic Ultra Porcine Bioprosthesis - Hemodynamic Study
Status:
COMPLETED
Status Verified Date:
2015-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The special fixation methodology of the Mosaic Ultra stented procine bioprosthesis allows valves to maintain their natural leaflet structure and root geometry which prevents leaflet calcification and improves hemodynamic performance and a potential for increased durability This study will document the hemodynamic performance as assessed by echocardiographic recordings at six months post implantation
Detailed Description:
10 STUDY PLAN 11 Study Objectives The objective of this clinical study is to evaluate the hemodynamic performance of the Mosaic Ultra stented porcine bioprosthesis in the aortic position
12 Study Design This will be a prospective non randomized multi center clinical study designed to obtain hemodynamic data on the Mosaic Ultra stented porcine bioprosthesis All participating centers follow a common clinical investigation plan
13 Sample Size and Study Duration The basis for this study will be at least 60 MosaicÒ Ultra stented porcine bioprosthesis implants followed for six months
20 PATIENT SELECTION 21 Patient Eligibility Criteria The patient population includes all patients who require aortic valve replacement for heart valve disease acquired or congenital and who are candidates for a bioprosthetic valve Patients will be informed about the aspects of this study and will be asked to give their Informed Consent The patient population must be geographically stable and able to attend one follow-up examination at the implanting center Patients not willing or unable to fully participate in the follow-up will not be entered in the study
22 Inclusion Criteria
Patients who require aortic valve replacement with or without coronary artery bypass grafting or surgical treatment of Atrial Fibrillation
Patients who are able to provide informed consent
33 Exclusion Criteria
Concomitant procedures other than coronary artery bypass grafting or surgical treatment of Atrial Fibrillation
Patients indicated for receiving a mechanical prosthesis
Patients who will have a replacement of an existing valve prosthesis
Patients refusing or not able to provide informed consent
Patients requiring emergency surgery
40 STUDY METHODS 41 Data Requirements For each patient enrolled in the study information will be collected pre-operatively operatively and at 6 months post-operatively
Patients entering the study are preoperatively evaluated for clinical information Upon implant of the Mosaic bioprostheses the appropriate surgical data will be obtained Follow-up data are required at discharge and six months post-operative Endpoint for each patient in the study will be the six months follow-up
The required variables are specified on each CRF Samples of the CRFs are provided in Appendix C Transthoracic echocardiography is required at pre-op and at six months
All centers will be provided with a unique center ID Enrolled patients will be identified on the CRFs by using the center ID with a sequential three digit number
42 Case Report Form CRF Completion All appropriate sections of the case report forms must be filled out completely and accurately in black or blue ink Before submission to Medtronic the investigator or designated co-investigator must review sign and date the CRFs The original is sent to Medtronic and a copy remains at the center in the patient study file All efforts should be made to submit CRFs to Medtronic within 6 weeks after the examination
43 Study File A study file will be set up and maintained by the study center This will be the repository for all records related to the study All case report forms should be traceable to source documents Source documents must be maintained in the patient medical records
50 DATA ANALYSIS AND REPORTING 51 Data ownership All data collected in this study will be regarded as confidential and will be entered in a common database that is the property of Medtronic
52 Data analysis Appropriate statistical analysis will be performed to compare the hemodynamic performance of various sizes Hemodynamic data will be summarized by valve size Descriptive statistics will be employed to report patient population characteristics operative and post-operative data
53 Data reporting Medtronic will complete and submit to the participating investigators a complete report using all collected data
54 Publication policy It is the intent of both Medtronic and the study center that the investigator publish the results of this study Medtronic may elect to use the data and outcomes of this study for the promotion of its products Investigator will provide a copy of any abstract presentation andor manuscript to Medtronic at least thirty 30 days prior to submission Medtronic has the right to review the publications for confidential information copyright materials and to edit for technical accuracy prior to submission
60 STUDY MANAGEMENT 61 Study Sponsor and Contact Staff Medtronic Bakken Research Center BV is the sponsor of this study
Bèr Kleijnen Sr Clinical Research Specialist will be the contact person for the overall study coordination
Bèr Kleijnen Sr Clinical Research Specialist Cardiac Surgery Clinical Operations Bakken Research Center BV Endepolsdomein 5 6229 GW Maastricht The Netherlands emailberkleijnenmedtroniccom
Your local Sales representative will be the contact person for the daily coordination and data collection
62 Records Retention Records must be retained at each clinical site for a period of 2 years after the date the study is completed or terminated and in accordance with local record retention requirement
Medtronic will maintain clinical study records permanently
12 Study Design This will be a prospective non randomized multi center clinical study designed to obtain hemodynamic data on the Mosaic Ultra stented porcine bioprosthesis All participating centers follow a common clinical investigation plan
13 Sample Size and Study Duration The basis for this study will be at least 60 MosaicÒ Ultra stented porcine bioprosthesis implants followed for six months
20 PATIENT SELECTION 21 Patient Eligibility Criteria The patient population includes all patients who require aortic valve replacement for heart valve disease acquired or congenital and who are candidates for a bioprosthetic valve Patients will be informed about the aspects of this study and will be asked to give their Informed Consent The patient population must be geographically stable and able to attend one follow-up examination at the implanting center Patients not willing or unable to fully participate in the follow-up will not be entered in the study
22 Inclusion Criteria
Patients who require aortic valve replacement with or without coronary artery bypass grafting or surgical treatment of Atrial Fibrillation
Patients who are able to provide informed consent
33 Exclusion Criteria
Concomitant procedures other than coronary artery bypass grafting or surgical treatment of Atrial Fibrillation
Patients indicated for receiving a mechanical prosthesis
Patients who will have a replacement of an existing valve prosthesis
Patients refusing or not able to provide informed consent
Patients requiring emergency surgery
40 STUDY METHODS 41 Data Requirements For each patient enrolled in the study information will be collected pre-operatively operatively and at 6 months post-operatively
Patients entering the study are preoperatively evaluated for clinical information Upon implant of the Mosaic bioprostheses the appropriate surgical data will be obtained Follow-up data are required at discharge and six months post-operative Endpoint for each patient in the study will be the six months follow-up
The required variables are specified on each CRF Samples of the CRFs are provided in Appendix C Transthoracic echocardiography is required at pre-op and at six months
All centers will be provided with a unique center ID Enrolled patients will be identified on the CRFs by using the center ID with a sequential three digit number
42 Case Report Form CRF Completion All appropriate sections of the case report forms must be filled out completely and accurately in black or blue ink Before submission to Medtronic the investigator or designated co-investigator must review sign and date the CRFs The original is sent to Medtronic and a copy remains at the center in the patient study file All efforts should be made to submit CRFs to Medtronic within 6 weeks after the examination
43 Study File A study file will be set up and maintained by the study center This will be the repository for all records related to the study All case report forms should be traceable to source documents Source documents must be maintained in the patient medical records
50 DATA ANALYSIS AND REPORTING 51 Data ownership All data collected in this study will be regarded as confidential and will be entered in a common database that is the property of Medtronic
52 Data analysis Appropriate statistical analysis will be performed to compare the hemodynamic performance of various sizes Hemodynamic data will be summarized by valve size Descriptive statistics will be employed to report patient population characteristics operative and post-operative data
53 Data reporting Medtronic will complete and submit to the participating investigators a complete report using all collected data
54 Publication policy It is the intent of both Medtronic and the study center that the investigator publish the results of this study Medtronic may elect to use the data and outcomes of this study for the promotion of its products Investigator will provide a copy of any abstract presentation andor manuscript to Medtronic at least thirty 30 days prior to submission Medtronic has the right to review the publications for confidential information copyright materials and to edit for technical accuracy prior to submission
60 STUDY MANAGEMENT 61 Study Sponsor and Contact Staff Medtronic Bakken Research Center BV is the sponsor of this study
Bèr Kleijnen Sr Clinical Research Specialist will be the contact person for the overall study coordination
Bèr Kleijnen Sr Clinical Research Specialist Cardiac Surgery Clinical Operations Bakken Research Center BV Endepolsdomein 5 6229 GW Maastricht The Netherlands emailberkleijnenmedtroniccom
Your local Sales representative will be the contact person for the daily coordination and data collection
62 Records Retention Records must be retained at each clinical site for a period of 2 years after the date the study is completed or terminated and in accordance with local record retention requirement
Medtronic will maintain clinical study records permanently
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None